Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2007, p. 3277-3280, Vol. 45, No. 10
0095-1137/07/$08.00+0 doi:10.1128/JCM.02048-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Clinical Microbiology, Department of Pathology,1 Division of Infectious Diseases, Hackensack University Medical Center, Hackensack, New Jersey2
Received 4 October 2006/ Returned for modification 1 December 2006/ Accepted 20 July 2007
We report on an analysis of sequential isolates of Staphylococcus epidermidis from cultures of blood obtained from a patient with acute myeloid leukemia while the patient was receiving linezolid treatment. All 12 isolates had a linezolid MIC of 32 µg/ml. A 420-bp domain V region of the 23S rRNA gene from all isolates was amplified, and their nucleotide sequences were determined. A G2576T mutation was identified in all isolates. It was estimated that 67% of the 23S rRNA genes carried this mutation. This is the first report of the failure of linezolid treatment for Staphylococcus epidermidis bacteremia associated with a G2576T mutation in an immunocompromised patient.
Published ahead of print on 1 August 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»